AnaptysBio, Inc. (ANAB) Misses Q1 EPS by 5c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.64), $0.05 worse than the analyst estimate of ($1.59).

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
• Oracle’s Ellison cancels plan to sell up to 50 mln shares